AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 1-25/59
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE
Authors: BERG SL MURRY DJ MCCULLY CL GODWIN K BALIS FM
Citation: Sl. Berg et al., PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE, Clinical cancer research, 4(11), 1998, pp. 2891-2894
PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS
Authors: BERG SL BLANEY SM ADAMSON PC OBRIEN M POPLACK DG ARNDT C BLATT J BALIS FM
Citation: Sl. Berg et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS, Journal of clinical oncology, 16(1), 1998, pp. 181-186
PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 9-AMINOCAMPTOTHECIN (9-AC), IRINOTECAN (CPT-11), AND SN-38 IN NONHUMAN-PRIMATES
Authors: BLANEY SM TAKIMOTO C MURRY DJ KUTTESCH N MCCULLY C COLE DE GODWIN K BALIS FM
Citation: Sm. Blaney et al., PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 9-AMINOCAMPTOTHECIN (9-AC), IRINOTECAN (CPT-11), AND SN-38 IN NONHUMAN-PRIMATES, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 464-468
PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING
Authors: MUELLER BU ANDERSON BD FARLEY MQ MURPHY R ZUCKERMAN J JAROSINSKI P GODWIN K MCCULLY CL MITSUYA H PIZZO PA BALIS FM
Citation: Bu. Mueller et al., PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1815-1818
A PHASE I II STUDY OF THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN WITH HIV-INFECTION/
Authors: MUELLER BU SLEASMAN J NELSON RP SMITH S DEUTSCH PJ JU W STEINBERG SM BALIS FM JAROSINSKI PF BROUWERS P MISTRY G WINCHELL G ZWERSKI S SEI SZ WOOD LV ZEICHNER S PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN WITH HIV-INFECTION/, Pediatrics (Evanston), 102(1), 1998, pp. 101-109
A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: MUELLER BU NELSON RP SLEASMAN J ZUCKERMAN J HEATHCHIOZZI M STEINBERG SM BALIS FM BROUWERS P HSU A SAULIS R SEI S WOOD LV ZEICHNER S KATZ TTK HIGHAM C AKER D EDGERLY M JAROSINSKI P SERCHUCK L WHITCUP SM PIZZUTI D PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 101(3), 1998, pp. 335-343
PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY
Authors: BALIS FM HOLCENBERG JS POPLACK DG GE J SATHER HN MURPHY RF AMES MM WASKERWITZ MJ TUBERGEN DG ZIMM S GILCHRIST GS BLEYER WA
Citation: Fm. Balis et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY, Blood, 92(10), 1998, pp. 3569-3577
A PILOT-STUDY OF GAMMA-1B-INTERFERON IN COMBINATION WITH FLUOROURACIL, LEUCOVORIN, AND INTERFERON-ALPHA-2A
Authors: GREM JL MCATEE N MURPHY RF BALIS FM CULLEN E CHEN AIP HAMILTON JM STEINBERG SM QUINN M SORENSEN JM ARBUCK SG LAWRENCE D PANG JE ALLEGRA CJ
Citation: Jl. Grem et al., A PILOT-STUDY OF GAMMA-1B-INTERFERON IN COMBINATION WITH FLUOROURACIL, LEUCOVORIN, AND INTERFERON-ALPHA-2A, Clinical cancer research, 3(7), 1997, pp. 1125-1134
A PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF THIOGUANINE ADMINISTERED BY CONTINUOUS IV INFUSION
Authors: KITCHEN BJ BALIS FM POPLACK DG OBRIEN M CRAIG CE ADAMSON PC
Citation: Bj. Kitchen et al., A PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF THIOGUANINE ADMINISTERED BY CONTINUOUS IV INFUSION, Clinical cancer research, 3(5), 1997, pp. 713-717
CARBOXYPEPTIDASE-G(2), THYMIDINE, AND LEUCOVORIN RESCUE IN CANCER-PATIENTS WITH METHOTREXATE-INDUCED RENAL DYSFUNCTION
Authors: WIDEMANN BC BALIS FM MURPHY RF SORENSEN JM MONTELLO MJ OBRIEN M ADAMSON PC
Citation: Bc. Widemann et al., CARBOXYPEPTIDASE-G(2), THYMIDINE, AND LEUCOVORIN RESCUE IN CANCER-PATIENTS WITH METHOTREXATE-INDUCED RENAL DYSFUNCTION, Journal of clinical oncology, 15(5), 1997, pp. 2125-2134
PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL
Authors: BLANEY SM SEIBEL NL OBRIEN M REAMAN GH BERG SL ADAMSON PC POPLACK DG KRAILO MD MOSHER R BALIS FM
Citation: Sm. Blaney et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1538-1543
PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER
Authors: ADAMSON PC REAMAN G FINKLESTEIN JZ FEUSNER J BERG SL BLANEY SM OBRIEN M MURPHY RF BALIS FM
Citation: Pc. Adamson et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3330-3337
FLUORESCENCE PROPERTIES OF A NEW GUANOSINE ANALOG INCORPORATED INTO SMALL OLIGONUCLEOTIDES
Authors: DRISCOLL SL HAWKINS ME BALIS FM PFLEIDERER W LAWS WR
Citation: Sl. Driscoll et al., FLUORESCENCE PROPERTIES OF A NEW GUANOSINE ANALOG INCORPORATED INTO SMALL OLIGONUCLEOTIDES, Biophysical journal, 73(6), 1997, pp. 3277-3286
A HYBRIDIZATION PROBE CONTAINING A FLUORESCENT GUANOSINE ANALOG WITH INCREASED FLUORESCENCE INTENSITY UPON FORMATION OF A HAIRPIN
Authors: HAWKINS ME SCHULTE TW BALIS FM
Citation: Me. Hawkins et al., A HYBRIDIZATION PROBE CONTAINING A FLUORESCENT GUANOSINE ANALOG WITH INCREASED FLUORESCENCE INTENSITY UPON FORMATION OF A HAIRPIN, Biophysical journal, 72(2), 1997, pp. 371-371
FLUORESCENCE PROPERTIES OF PTERIDINE NUCLEOSIDE ANALOGS AS MONOMERS AND INCORPORATED INTO OLIGONUCLEOTIDES
Authors: HAWKINS ME PFLEIDERER W BALIS FM PORTER D KNUTSON JR
Citation: Me. Hawkins et al., FLUORESCENCE PROPERTIES OF PTERIDINE NUCLEOSIDE ANALOGS AS MONOMERS AND INCORPORATED INTO OLIGONUCLEOTIDES, Analytical biochemistry, 244(1), 1997, pp. 86-95
PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: TOLCHER AW COWAN KH SOLOMON D OGNIBENE F GOLDSPIEL B CHANG R NOONE MH DENICOFF AM BARNES CS GOSSARD MR FETSCH PA BERG SL BALIS FM VENZON DJ OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1173-1184
RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN
Authors: WEXLER LH ANDRICH MP VENZON D BERG SL WEAVERMCCLURE L CHEN CC DILSIZIAN V AVILA N JAROSINSKI P BALIS FM POPLACK DG HOROWITZ ME
Citation: Lh. Wexler et al., RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN, Journal of clinical oncology, 14(2), 1996, pp. 362-372
IFOSFAMIDE AND ETOPOSIDE PLUS VINCRISTINE, DOXORUBICIN, AND CYCLOPHOSPHAMIDE FOR NEWLY-DIAGNOSED EWINGS-SARCOMA FAMILY OF TUMORS
Authors: WEXLER LH DELANEY TF TSOKOS M AVILA N STEINBERG SM WEAVERMCCLURE L JACOBSON J JAROSINSKI P HIJAZI YM BALIS FM HOROWITZ ME
Citation: Lh. Wexler et al., IFOSFAMIDE AND ETOPOSIDE PLUS VINCRISTINE, DOXORUBICIN, AND CYCLOPHOSPHAMIDE FOR NEWLY-DIAGNOSED EWINGS-SARCOMA FAMILY OF TUMORS, Cancer, 78(4), 1996, pp. 901-911
PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS
Authors: BLANEY SM PHILLIPS PC PACKER RJ HEIDEMAN RL BERG SL ADAMSON PC ALLEN JC SALLAN SE JAKACKI RL LANGE BJ REAMAN GH HOROWITZ ME POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS, Cancer, 78(3), 1996, pp. 527-531
STUDIES ON THE FLUORESCENT NUCLEOTIDE 3-METHYL-ISOXANTHOPTERINE INCORPORATED INTO OLIGONUCLEOTIDES
Authors: DRISCOLL S HAWKINS M BALIS FM PFEIDERER W LAWS WR
Citation: S. Driscoll et al., STUDIES ON THE FLUORESCENT NUCLEOTIDE 3-METHYL-ISOXANTHOPTERINE INCORPORATED INTO OLIGONUCLEOTIDES, Biophysical journal, 70(2), 1996, pp. 132-132
CYTOTOXICITY AND DNA-DAMAGE ASSOCIATED WITH PYRAZOLOACRIDINE IN MCF-7BREAST-CANCER CELLS
Authors: GREM JL POLITI PM BERG SL BENCHEKROUN NM PATEL M BALIS FM SINHA BK DAHUT W ALLEGRA CJ
Citation: Jl. Grem et al., CYTOTOXICITY AND DNA-DAMAGE ASSOCIATED WITH PYRAZOLOACRIDINE IN MCF-7BREAST-CANCER CELLS, Biochemical pharmacology, 51(12), 1996, pp. 1649-1659
PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY
Authors: WILSON WH JAMISDOW C BRYANT G BALIS FM KLECKER RW BATES SE CHABNER BA STEINBERG SM KOHLER DR WITTES RE
Citation: Wh. Wilson et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1985-1994
EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER
Authors: BERG SL TOLCHER A OSHAUGHNESSY JA DENICOFF AM NOONE M OGNIBENE FP COWAN KH BALIS FM
Citation: Sl. Berg et al., EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2039-2042
Risultati: 1-25 | 26-50 | 51-59